Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

331
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
331
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Phenome-Wide Comparative Analysis of Individualized Network Heterogeneity Across Treatment-Response Subphenotypes in Coronary Heart Disease.

Biology·2026
Same author

Resting-State fMRI and Post-Ischemic Stroke Functional Recovery: Unraveling Causality and Predicting Therapeutic Targets.

International journal of molecular sciences·2025
Same author

Titanium dioxide nanoparticles relieve biochemical dysfunctions of fifth-instar larvae of silkworms following exposure to phoxim insecticide.

Chemosphere·2012
Same author

Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: an experimental study in a rat model of benign prostatic hyperplasia.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban·2012
Same author

Simulation and experimental investigation of structural dynamic frequency characteristics control.

Sensors (Basel, Switzerland)·2012
Same author

Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression.

Journal of affective disorders·2012

相关实验视频

Updated: Jun 11, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

Syn-COM:创新药物组合的多层预测协同框架.

Yinli Shi1, Jun Liu1, Shuang Guan1

  • 1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Pharmaceuticals (Basel, Switzerland)
|September 28, 2024
PubMed
概括
此摘要是机器生成的。

本研究介绍了Syn-COM,这是一个用于预测药物组合的生物信息学框架. 它确定了一种有效的传统中医治疗痛风性关节炎的方法,经过实验和基因分析验证.

关键词:
人工智能的人工智能是人工智能.药物组合是药物组合.公式设计 公式设计 公式设计痛风性关节炎是一种关节炎.类似性聚类类似性聚类.协同效应指数是一个协同效应指数.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K

相关实验视频

Last Updated: Jun 11, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K

科学领域:

  • 生物信息学和计算生物学
  • 药理学和药物发现
  • 传统中国医学 (TCM) 是一种

背景情况:

  • 药物预测和治疗正在通过生物信息学和大规模建模进步.
  • 整合不同的数据源对于确定最佳药物组合至关重要.
  • 传统中医提供了丰富的潜在治疗药物的来源.

研究的目的:

  • 提出一个新的多层次合作框架 (Syn-COM),用于疾病和药物的特征提取和数据集成.
  • 用分子,相似性和基于网络的方法探索最佳的药物组合和相互作用.
  • 验证框架的可靠性,并确定治疗痛风性关节炎 (GA) 的有效药物组合.

主要方法:

  • 开发了Syn-COM框架,集成了分子虚拟性,相似性聚类,重叠区域和网络距离.
  • 利用协同矩阵来评估药物相互作用和相关性,结合TCM特征和临床经验.
  • 将框架应用于痛风性关节炎 (GA) 作为一个案例研究.

主要成果:

  • 确定了一种对GA的强效药物组合:Tamaricis Cacumen,Cuscutae Semen,Artemisiae Annuae Herba,Schizonepetae Herba,Gleditsiae Spina,Prunellae Spica,以及Achyranthis Bidentatae Radix. 这三种药物被认为是最有效的药物组合.
  • 通过动物实验验证的疗效,显示IL1A,IL6,尿酸的显著降低,以及TGFB1,PTGS2,MMP3的下调 (p <0.05).
  • 在GA小鼠中观察到脚关节胀的改善,证实了治疗效益.

结论:

  • Syn-COM框架有效地整合了用于药物发现和治疗预测的多层次数据.
  • 鉴定到的TCM药物组合表明了对痛风性关节炎的显著治疗潜力.
  • 将传统医学与现代生物信息学相结合,为增强疾病治疗提供了一个有希望的途径.